The market for electroceuticals was valued at USD 23.30 billion in 2022 and is anticipated to grow at a 5.6% CAGR in terms of revenue during the projected period. The rising incidence of cardiovascular and neurological diseases is a major driver fueling market revenue growth. Worldwide, cardiovascular illnesses, such as heart disease and stroke, claim the lives of over 18.6 million people each...